Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cozzi

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Journal of Endocrinological Investigation|November 5, 1998
Scintigraphic imaging of pituitary adenomas: an in vivo evaluation of somatostatin receptorsG Oppizzi, R Cozzi, D Dallabonzana, et al.
Metabolism: Clinical and Experimental|May 8, 2004
Effects of the selective estrogen receptor modulator LY117018 on growth hormone secretion: In vitro studiesG Tulipano, C Bonfanti, C Poiesi, et al.
The Journal of Biological Chemistry|January 23, 1999
Identification of domains responsible for von Willebrand factor type VI collagen interaction mediating platelet adhesion under high flowM Mazzucato, P Spessotto, A Masotti, et al.
Journal of Endocrinological Investigation|June 1, 1991
Doxorubicin for acromegaly: a case reportR Attanasio, P Orlandi, D Dallabonzana, et al.
Journal of Endocrinological Investigation|October 1, 1980
Effectiveness of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic statesG Verde, P G Chiodini, A Liuzzi, et al.
Neuroendocrinology|June 16, 2001
Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitroG Tulipano, C Bonfanti, G Milani, et al.
Clinical Endocrinology|January 1, 1980
Size reduction of a prolactin secreting adenoma during long-term treatment with the dopamine agonist lisurideP G Chiodini, A Liuzzi, G Verde, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1981
Size reduction of macroprolactinomas by bromocriptine or lisuride treatmentP Chiodini, A Liuzzi, R Cozzi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2007
Prothrombotic effects of fibronectin isoforms containing the EDA domainAnil K Chauhan, Janka Kisucka, Maria R Cozzi, et al.
Journal of Endocrinological Investigation|June 23, 2009
Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegalyG Lombardi, F Minuto, G Tamburrano, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Journal of Endocrinological Investigation|November 5, 1998
Scintigraphic imaging of pituitary adenomas: an in vivo evaluation of somatostatin receptorsG Oppizzi, R Cozzi, D Dallabonzana, et al.
Metabolism: Clinical and Experimental|May 8, 2004
Effects of the selective estrogen receptor modulator LY117018 on growth hormone secretion: In vitro studiesG Tulipano, C Bonfanti, C Poiesi, et al.
The Journal of Biological Chemistry|January 23, 1999
Identification of domains responsible for von Willebrand factor type VI collagen interaction mediating platelet adhesion under high flowM Mazzucato, P Spessotto, A Masotti, et al.
Journal of Endocrinological Investigation|June 1, 1991
Doxorubicin for acromegaly: a case reportR Attanasio, P Orlandi, D Dallabonzana, et al.
Journal of Endocrinological Investigation|October 1, 1980
Effectiveness of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic statesG Verde, P G Chiodini, A Liuzzi, et al.
Neuroendocrinology|June 16, 2001
Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitroG Tulipano, C Bonfanti, G Milani, et al.
Clinical Endocrinology|January 1, 1980
Size reduction of a prolactin secreting adenoma during long-term treatment with the dopamine agonist lisurideP G Chiodini, A Liuzzi, G Verde, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1981
Size reduction of macroprolactinomas by bromocriptine or lisuride treatmentP Chiodini, A Liuzzi, R Cozzi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2007
Prothrombotic effects of fibronectin isoforms containing the EDA domainAnil K Chauhan, Janka Kisucka, Maria R Cozzi, et al.
Journal of Endocrinological Investigation|June 23, 2009
Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegalyG Lombardi, F Minuto, G Tamburrano, et al.
Pageof 8